Clinical Trials in Haugesund, Norway
4 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled129 locationsNCT07222332
Recruiting
Phase 4
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Rheumatoid Arthritis
Diakonhjemmet Hospital350 enrolled22 locationsNCT06440629
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
Plasma Cell LeukemiaMyeloma, MultipleAL Amyloidosis
St. Olavs Hospital400 enrolled23 locationsNCT06855121
Recruiting
Phase 2
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Alzheimer DiseaseCognitive Decline, Mild
Helse Stavanger HF200 enrolled6 locationsNCT06362707
Recruiting
MicroRNA as Markers in Testicular Cancer
SeminomaTesticular Germ Cell CancerNon-Seminoma Testicular Cancer+5 more
Haukeland University Hospital350 enrolled6 locationsNCT04914026